Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Mohnish Pabrai's Top Q2 2026 Move: Trimming Alpha Metallurgical Resources Inc at a -3.04% Portfolio Impact
Warrior Met Coal Q2 Earnings Call Highlights
Warrior Met Coal, Inc. (HCC) Q2 2026 Earnings Call Transcript
Warrior Met Coal (HCC) Surpasses Q2 Earnings and Revenue Estimates
Warrior Reports Second Quarter 2026 Results
Warrior Met Coal (HCC) Earnings Expected to Grow: Should You Buy?
Warrior Announces Regular Quarterly Cash Dividend
Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers
Fifth Third Bancorp Has $1.12 Million Stock Position in Warrior Met Coal $HCC
Warrior Sets Date for Second Quarter 2026 Earnings Announcement and Investor Conference Call
HCC Healthcare Signs Business Combination Agreement with RF Acquisition Corp III to Pursue Nasdaq Listing
TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer
Warrior Met Coal Inc (HCC) Shares Fall 4.3% -- What GF Score of 81 Tells Investors
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
This $4 Million Warrior Met Coal Sale May Be More About Profit Taking Than Coal Prices
Warrior Met Coal, Inc. (HCC) Q1 2026 Earnings Call Transcript
Warrior Met Coal (HCC) Tops Q1 Earnings and Revenue Estimates
Warrior Reports First Quarter 2026 Results